5 Treatment Options For ATTR-CM

When it comes to diagnosing ATTR-CM (transthyretin amyloid cardiomyopathy), it is essential to understand its manifestations and available treatment options. ATTR-CM is a rare, progressive disease that occurs when abnormal protein deposits build up in the heart, leading to heart failure. In this essay, we will explore the symptoms of ATTR-CM, the different pharmacological interventions available, the role of heart transplantation in advanced cases, and how each patient must carefully consider what is best for them. Symptoms ATTR-CM symptoms can vary from person to person, making diagnosis challenging. Patients often experience:  shortness of breath fatigue swelling in the legs and ankles Dizziness, difficulties exercising, and an irregular heartbeat are some of the other symptoms that may be present. Therefore, it is essential to recognize these symptoms and seek medical assistance as soon as possible to get an appropriate diagnosis. RELATED: What Black folks Need To Know About ATTR-CM Pharmacological Interventions The goal of pharmacological therapies for ATTR-CM is to effectively control symptoms and slow down the evolution of the illness when it is present. On the market today, there are two primary categories of medications: TTR stabilizers  Gene silencers To stop the aberrant protein from accumulating in the heart, TTR...